Other Issues:		[Index by Author]
Contents:	Volume 27, Issue 25 September 1, 2009

	EDITORIALS
	COMMENTS AND CONTROVERSIES
	ORIGINAL REPORTS
	Genitourinary Cancer
	Breast Cancer
	Gastrointestinal Cancer
	Thoracic Oncology
	Cancer-Related Complications
	Palliative and Supportive Care
	Clinical Trials
	Gynecologic Cancer
	Neurooncology
	Other Malignancies
	Phase I and Clinical Pharmacology
	Health Services and Outcomes
	Sarcomas
	Hematologic Malignancies
	BIOLOGY OF NEOPLASIA
	ART OF ONCOLOGY
	DIAGNOSIS IN ONCOLOGY
	CORRESPONDENCE

Find articles in this issue containing these words: [Search ALL Issues]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

                                      EDITORIALS

Immunotherapy for Prostate Cancer: Walk, Don't Run Charles G. Drake JCO Sep 2009: 4035–4037. First published on Jul 27 2009; 10.1200/JCO.2009.22.2299. [Full Text] [PDF]

More Mastectomies: Is This What Patients Really Want? Monica Morrow and Jay R. Harris JCO Sep 2009: 4038–4040. First published on Jul 27 2009; 10.1200/JCO.2009.23.0078. [Full Text] [PDF]

Radioembolization of Liver Metastases in Patients With Colorectal Cancer: A Nonsurgical Treatment With Combined Modality Potential J. Philip Kuebler JCO Sep 2009: 4041–4042. First published on Aug 3 2009; 10.1200/JCO.2009.23.2785. [Full Text] [PDF]

                                      COMMENTS AND CONTROVERSIES

Sowing the Soil for Cure? Results of the ABCSG-12 Trial Open a New Chapter in the Evolving Adjuvant Bisphosphonate Story in Early Breast Cancer Philippe L. Bedard, Jean-Jacques Body, and Martine J. Piccart-Gebhart JCO Sep 2009: 4043–4046. First published on Aug 3 2009; 10.1200/JCO.2008.21.4908. [Full Text] [PDF]

                                      ORIGINAL REPORTS
Genitourinary Cancer

Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer Douglas G. McNeel, Edward J. Dunphy, James G. Davies, Thomas P. Frye, Laura E. Johnson, Mary Jane Staab, Dorothea L. Horvath, Jane Straus, Dona Alberti, Rebecca Marnocha, Glenn Liu, Jens C. Eickhoff, and George Wilding JCO Sep 2009: 4047–4054. First published on Jul 27 2009; 10.1200/JCO.2008.19.9968. [Abstract] [Full Text] [PDF]

Late Pelvic Toxicity After Bladder-Sparing Therapy in Patients With Invasive Bladder Cancer: RTOG 89-03, 95-06, 97-06, 99-06 Jason A. Efstathiou, Kyounghwa Bae, William U. Shipley, Donald S. Kaufman, Michael P. Hagan, Niall M. Heney, and Howard M. Sandler JCO Sep 2009: 4055–4061. First published on Jul 27 2009; 10.1200/JCO.2008.19.5776. [Abstract] [Full Text] [PDF]

Final Results of Sequential Doxorubicin Plus Gemcitabine and Ifosfamide, Paclitaxel, and Cisplatin Chemotherapy in Patients With Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium Matthew I. Milowsky, David M. Nanus, Fernando C. Maluf, Svetlana Mironov, Weiji Shi, Alexia Iasonos, Jamie Riches, Ashley Regazzi, and Dean F. Bajorin JCO Sep 2009: 4062–4067. First published on Jul 27 2009; 10.1200/JCO.2008.21.2241. [Abstract] [Full Text] [PDF]

Phase II Study of Sunitinib Administered in a Continuous Once-Daily Dosing Regimen in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma Bernard Escudier, Jan Roigas, Silke Gillessen, Ulrika Harmenberg, Sandhya Srinivas, Sasja F. Mulder, George Fountzilas, Christian Peschel, Per Flodgren, Edna Chow Maneval, Isan Chen, and Nicholas J. Vogelzang JCO Sep 2009: 4068–4075. First published on Aug 3 2009; 10.1200/JCO.2008.20.5476. [Abstract] [Full Text] [PDF]

Phase II Presurgical Feasibility Study of Bevacizumab in Untreated Patients With Metastatic Renal Cell Carcinoma Eric Jonasch, Christopher G. Wood, Surena F. Matin, Shi-Ming Tu, Lance C. Pagliaro, Paul G. Corn, Ana Aparicio, Pheroze Tamboli, Randall E. Millikan, Xuemei Wang, John C. Araujo, Wadih Arap, and Nizar Tannir JCO Sep 2009: 4076–4081. First published on Jul 27 2009; 10.1200/JCO.2008.21.3660. [Abstract] [Full Text] [PDF]

Breast Cancer

Trends in Mastectomy Rates at the Mayo Clinic Rochester: Effect of Surgical Year and Preoperative Magnetic Resonance Imaging Rajini Katipamula, Amy C. Degnim, Tanya Hoskin, Judy C. Boughey, Charles Loprinzi, Clive S. Grant, Kathleen R. Brandt, Sandhya Pruthi, Christopher G. Chute, Janet E. Olson, Fergus J. Couch, James N. Ingle, and Matthew P. Goetz JCO Sep 2009: 4082–4088. First published on Jul 27 2009; 10.1200/JCO.2008.19.4225. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer

Treatment of Fluorouracil-Refractory Patients With Liver Metastases From Colorectal Cancer by Using Yttrium-90 Resin Microspheres Plus Concomitant Systemic Irinotecan Chemotherapy Guy A. van Hazel, Nick Pavlakis, David Goldstein, Ian N. Olver, Michael J. Tapner, David Price, Geoffrey D. Bower, Gregory M. Briggs, Monica A. Rossleigh, D. James Taylor, and Jacob George JCO Sep 2009: 4089–4095. First published on Aug 3 2009; 10.1200/JCO.2008.20.8116. [Abstract] [Full Text] [PDF]

Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer: Radiation Therapy Oncology Group RTOG 0411 Christopher H. Crane, Kathryn Winter, William F. Regine, Howard Safran, Tyvin A. Rich, Walter Curran, Robert A. Wolff, and Christopher G. Willett JCO Sep 2009: 4096–4102. First published on Jul 27 2009; 10.1200/JCO.2009.21.8529. [Abstract] [Full Text] [PDF]

Model-Based Prediction of Phase III Overall Survival in Colorectal Cancer on the Basis of Phase II Tumor Dynamics Laurent Claret, Pascal Girard, Paulo M. Hoff, Eric Van Cutsem, Klaas P. Zuideveld, Karin Jorga, Jan Fagerberg, and René Bruno JCO Sep 2009: 4103–4108. First published on Jul 27 2009; 10.1200/JCO.2008.21.0807. [Abstract] [Full Text] [PDF]

Racial Differences in Advanced Colorectal Cancer Outcomes and Pharmacogenetics: A Subgroup Analysis of a Large Randomized Clinical Trial Hanna K. Sanoff, Daniel J. Sargent, Erin M. Green, Howard L. McLeod, and Richard M. Goldberg JCO Sep 2009: 4109–4115. First published on Jul 27 2009; 10.1200/JCO.2009.21.9527. [Abstract] [Full Text] [PDF]

Thoracic Oncology

Phase I Dose Escalation, Pharmacokinetic and Pharmacodynamic Study of Naptumomab Estafenatox Alone in Patients With Advanced Cancer and With Docetaxel in Patients With Advanced Non–Small-Cell Lung Cancer Hossein Borghaei, Katherine Alpaugh, Gunnar Hedlund, Göran Forsberg, Corey Langer, Andre Rogatko, Robert Hawkins, Svein Dueland, Ulrik Lassen, and Roger B. Cohen JCO Sep 2009: 4116–4123. First published on Jul 27 2009; 10.1200/JCO.2008.20.2515. [Abstract] [Full Text] [PDF] [Publisher's Note]

Cancer-Related Complications

D-Dimer and Prothrombin Fragment 1 + 2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study Cihan Ay, Rainer Vormittag, Daniela Dunkler, Ralph Simanek, Alexandru-Laurentiu Chiriac, Johannes Drach, Peter Quehenberger, Oswald Wagner, Christoph Zielinski, and Ingrid Pabinger JCO Sep 2009: 4124–4129. First published on Jul 27 2009; 10.1200/JCO.2008.21.7752. [Abstract] [Full Text] [PDF]

Palliative and Supportive Care

Major Depressive Disorder in Long-Term Cancer Survivors: Analysis of the National Comorbidity Survey Replication William F. Pirl, Joseph Greer, Jennifer S. Temel, Beow Y. Yeap, and Stephen E. Gilman JCO Sep 2009: 4130–4134. First published on Jul 27 2009; 10.1200/JCO.2008.16.2784. [Abstract] [Full Text] [PDF]

Clinical Trials

Comparison of Power Between Randomized Discontinuation Design and Upfront Randomization Design on Progression-Free Survival Pingfu Fu, Afshin Dowlati, and Mark Schluchter JCO Sep 2009: 4135–4141. First published on Jul 27 2009; 10.1200/JCO.2008.19.6709. [Abstract] [Full Text] [PDF] [Publisher's Note]

Gynecologic Cancer

Chronic Physical Effects and Health Care Utilization in Long-Term Ovarian Germ Cell Tumor Survivors: A Gynecologic Oncology Group Study Daniela Matei, Anna M. Miller, Patrick Monahan, David Gershenson, Qianqian Zhao, David Cella, Victoria L. Champion, and Stephen D. Williams JCO Sep 2009: 4142–4149. First published on Jul 27 2009; 10.1200/JCO.2008.20.9189. [Abstract] [Full Text] [PDF]

Neurooncology

Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas Marc Sanson, Yannick Marie, Sophie Paris, Ahmed Idbaih, Julien Laffaire, François Ducray, Soufiane El Hallani, Blandine Boisselier, Karima Mokhtari, Khe Hoang-Xuan, and Jean-Yves Delattre JCO Sep 2009: 4150–4154. First published on Jul 27 2009; 10.1200/JCO.2009.21.9832. [Abstract] [Full Text] [PDF]

Talampanel With Standard Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma: A Multicenter Phase II Trial Stuart A. Grossman, Xiaobu Ye, Marc Chamberlain, Tom Mikkelsen, Tracy Batchelor, Serena Desideri, Steven Piantadosi, Joy Fisher, and Howard A. Fine JCO Sep 2009: 4155–4161. First published on Jul 27 2009; 10.1200/JCO.2008.21.6895. [Abstract] [Full Text] [PDF]

Other Malignancies

Phase II Study of High-Dose [131I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma Sara Gonias, Robert Goldsby, Katherine K. Matthay, Randall Hawkins, David Price, John Huberty, Lloyd Damon, Charles Linker, Aimee Sznewajs, Steve Shiboski, and Paul Fitzgerald JCO Sep 2009: 4162–4168. First published on Jul 27 2009; 10.1200/JCO.2008.21.3496. [Abstract] [Full Text] [PDF]

Phase I and Clinical Pharmacology

Phase I Dose Escalation Study of Telatinib, a Tyrosine Kinase Inhibitor of Vascular Endothelial Growth Factor Receptor 2 and 3, Platelet-Derived Growth Factor Receptor β, and c-Kit, in Patients With Advanced or Metastatic Solid Tumors Ferry A.L.M. Eskens, Neeltje Steeghs, Jaap Verweij, Johan L. Bloem, Olaf Christensen, Leni van Doorn, Jan Ouwerkerk, Maja J.A. de Jonge, Johan W.R. Nortier, Joern Kraetzschmar, Prabhu Rajagopalan, and Hans Gelderblom JCO Sep 2009: 4169–4176. First published on Jul 27 2009; 10.1200/JCO.2008.18.8193. [Abstract] [Full Text] [PDF]

Health Services and Outcomes

Comparison of Commission on Cancer–Approved and –Nonapproved Hospitals in the United States: Implications for Studies That Use the National Cancer Data Base Karl Y. Bilimoria, David J. Bentrem, Andrew K. Stewart, David P. Winchester, and Clifford Y. Ko JCO Sep 2009: 4177–4181. First published on Jul 27 2009; 10.1200/JCO.2008.21.7018. [Abstract] [Full Text] [PDF]

Cancer-Related Direct-to-Consumer Advertising: Awareness, Perceptions, and Reported Impact Among Patients Undergoing Active Cancer Treatment Gregory A. Abel, Harold J. Burstein, Nathanael D. Hevelone, and Jane C. Weeks JCO Sep 2009: 4182–4187. First published on Aug 3 2009; 10.1200/JCO.2008.20.6599. [Abstract] [Full Text] [PDF]

Sarcomas

Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules George D. Demetri, Sant P. Chawla, Margaret von Mehren, Paul Ritch, Laurence H. Baker, Jean Y. Blay, Kenneth R. Hande, Mary L. Keohan, Brian L. Samuels, Scott Schuetze, Claudia Lebedinsky, Yusri A. Elsayed, Miguel A. Izquierdo, Javier Gómez, Youn C. Park, and Axel Le Cesne JCO Sep 2009: 4188–4196. First published on Aug 3 2009; 10.1200/JCO.2008.21.0088. [Abstract] [Full Text] [PDF]

Hematologic Malignancies

Gene Expression Profiles of Tumor Biology Provide a Novel Approach to Prognosis and May Guide the Selection of Therapeutic Targets in Multiple Myeloma Ariel Anguiano, Sascha A. Tuchman, Chaitanya Acharya, Kelly Salter, Cristina Gasparetto, Fenghuang Zhan, Madhav Dhodapkar, Joseph Nevins, Bart Barlogie, John D. Shaughnessy, Jr, and Anil Potti JCO Sep 2009: 4197–4203. First published on Jul 27 2009; 10.1200/JCO.2008.19.1916. [Abstract] [Full Text] [PDF]

Impact of Baseline BCR-ABL Mutations on Response to Nilotinib in Patients With Chronic Myeloid Leukemia in Chronic Phase Timothy Hughes, Giuseppe Saglio, Susan Branford, Simona Soverini, Dong-Wook Kim, Martin C. Müller, Giovanni Martinelli, Jorge Cortes, Lan Beppu, Enrico Gottardi, Dongho Kim, Philipp Erben, Yaping Shou, Ariful Haque, Neil Gallagher, Jerald Radich, and Andreas Hochhaus JCO Sep 2009: 4204–4210. First published on Aug 3 2009; 10.1200/JCO.2009.21.8230. [Abstract] [Full Text] [PDF]

Anaplastic Lymphoma Kinase–Positive Diffuse Large B-Cell Lymphoma: A Rare Clinicopathologic Entity With Poor Prognosis Camille Laurent, Catherine Do, Randy D. Gascoyne, Laurence Lamant, Loïc Ysebaert, Guy Laurent, Georges Delsol, and Pierre Brousset JCO Sep 2009: 4211–4216. First published on Jul 27 2009; 10.1200/JCO.2008.21.5020. [Abstract] [Full Text] [PDF]

                                      BIOLOGY OF NEOPLASIA

Erythroid-Stimulating Agents in Cancer Therapy: Potential Dangers and Biologic Mechanisms Brandon K. Hadland and Gregory D. Longmore JCO Sep 2009: 4217–4226. First published on Jul 27 2009; 10.1200/JCO.2008.21.6945. [Abstract] [Full Text] [PDF]

                                      ART OF ONCOLOGY

The Forgotten Spouse Akash Nanda JCO Sep 2009: 4227–4228. First published on Jul 13 2009; 10.1200/JCO.2009.22.1069. [Full Text] [PDF]

                                      DIAGNOSIS IN ONCOLOGY

Management of Anaplastic Large-Cell Lymphoma During Pregnancy Fedro A. Peccatori, Hatem A. Azim, Jr, Giancarlo Pruneri, Gaia Piperno, Paola R. Raviele, Lorenzo Preda, Mario Ciocca, Roberto Orecchia, and Giovanni Martinelli JCO Sep 2009: e75–e77. First published on Jun 8 2009; 10.1200/JCO.2009.22.2042. [Full Text] [PDF]

Plasmablastic Lymphoma in an Immunocompetent Patient Charu Thakral, Lilian Thomas, Ajeet Gajra, Robert E. Hutchison, Gregory C. Ravizzini, and Neerja Vajpayee JCO Sep 2009: e78–e81. First published on Jul 6 2009; 10.1200/JCO.2009.22.2208. [Full Text] [PDF]

                                      CORRESPONDENCE

Duration of High-Dose Interferon Alfa-2b Regimen for Resected High-Risk Melanoma Sanjiv S. Agarwala, Robert J. Gray, and Michael K.K. Wong JCO Sep 2009: e82–e83. First published on Jul 27 2009; 10.1200/JCO.2009.23.0334. [Full Text] [PDF]

Reply to S.S. Agarwala et al Dimitrios Pectasides, Urania Dafni, and Helen Gogas JCO Sep 2009: e84. First published on Jul 27 2009; 10.1200/JCO.2009.23.2447. [Full Text] [PDF]

Gene Expression Profiling in Cancers of Unknown Primary Gauri R. Varadhachary and Martin N. Raber JCO Sep 2009: e85–e86. First published on Jul 27 2009; 10.1200/JCO.2009.23.7644. [Full Text] [PDF]

Reply to G.R. Varadhachary et al Federico A. Monzon, David W. Henner, C. Ted Rigl, Glenda G. Anderson, Ljubomir Buturovic, and Raji Pillai JCO Sep 2009: e87–e88. First published on Jul 27 2009; 10.1200/JCO.2009.23.7982. [Full Text] [PDF]

Effects of Anesthetics on Cancer Recurrence Jonathan Moss and Robert J. Israel JCO Sep 2009: e89. First published on Aug 3 2009; 10.1200/JCO.2009.23.7651. [Full Text] [PDF]

Reply to J. Moss and R. J. Israel Dorothea Weckermann, Helmuth Forst, Bernhard Polzer, and Christoph A. Klein JCO Sep 2009: e90. First published on Aug 3 2009; 10.1200/JCO.2009.23.7990. [Full Text] [PDF]

Risk of Depressive Events in Long-Term Surviving Patients Affected by Hormone-Related Cancer According to Time After Diagnosis Andrea Saini, Luca Ostacoli, Gabriella Gorzegno, Rocco Luigi Picci, Luigi Dogliotti, Pier Maria Furlan, and Alfredo Berruti JCO Sep 2009: e91–e92. First published on Aug 3 2009; 10.1200/JCO.2009.23.5663. [Full Text] [PDF]

Reply to A. Saini et al Susanne O. Dalton, Thomas Munk Laursen, Lone Ross, Preben Bo Mortensen, and Christoffer Johansen JCO Sep 2009: e93–e94. First published on Aug 3 2009; 10.1200/JCO.2009.23.6968. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.